false
Hamburger Menu
Catalog
JTO Clinical and Research Reports, March 2023, Vol ...
JTO Clinical and Research Reports, March 2023, Volume 4, Issue 3
Journal | English
Create Account
Availability
On-Demand
Cost
$0.00
Credit Offered
No Credit Offered
JTO Clinical and Research Reports, March 2023, Volume 4, Issue 3
Table of Contents
Editorial
Effectiveness and Safety of Atezolizumab Monotherapy in Previously Treated Japanese Patients With Unresectable Advanced or Recurrent NSCLC: A Multicenter, Prospective, Observational Study (J-TAIL)
Commentary
Comments on the Article by Miura et al.: “Comparable Clinical Benefit Between Different Subsets Selected by PD-L1 22C3 and SP142 Tests”
Original Articles:
Vidutolimod in Combination With Atezolizumab With and Without Radiation Therapy in Patients With Programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Blockade–Resistant Advanced NSCLC
Osimertinib in NSCLC With Atypical
EGFR
-Activating Mutations: A Retrospective Multicenter Study
Interventions Designed to Increase the Uptake of Lung Cancer Screening: An Equity-Oriented Scoping Review
The EGFR C797S Mutation Confers Resistance to a Novel EGFR Inhibitor CLN-081 to EGFR Exon 20 Insertion Mutations
Real-World Treatment Patterns and Effectiveness of Targeted and Immune Checkpoint Inhibitor-Based Systemic Therapy in
BRAF
Mutation-Positive NSCLC
Brief Reports
Application of the Novel Grading System of Invasive Pulmonary Adenocarcinoma in a Real Diagnostic Scenario: A Brief Report of 9353 Cases
Brief Report: Severe Pneumonitis After Combined Thoracic Radiotherapy and Osimertinib
About JTO Clinical and Research Reports
JTO Clinical and Research Reports
is the official open access journal of the
International Association for the Study of Lung Cancer
. It aims to complement the
Journal of Thoracic Oncology
by offering authors a gold open access publication option and publishing the following article types in particular:
Phase I trials
Well performed single-arm phase II trials
Subset analyses of published trials
Impactful retrospective Studies
Database analysis
Large institutional series
High-quality case reports
Region-specific clinical trials
Subspecialty thoracic oncology studies
Selected high-quality meeting reports
As an open access journal with no subscription charges,
JTO CRR
requires authors to pay a
fee
to cover the costs associated with publication. This ensures your article will be immediately and permanently free to access by everyone.
×
JTO Clinical and Research Reports, March 2023, Volume 4, Issue 3 Course List
Login
User Login
Continue with Google
OR
Email
Password
Logging In…
Create Account
Forgot Password
×
Please select your language
1
English